Back
Agfa-Gevaert NV Vs. Aligos Therapeutics Industry Stock Comparison
Sell
10
AFGVY
Agfa-Gevaert NV
Last Price:
$1.33
Seasonality Move:
3.44%
Buy
69
ALGS
Aligos Therapeutics
Last Price:
$43.44
Seasonality Move:
-17.17%
Sell
10
Agfa-Gevaert NV (AFGVY)
is a Sell
Is Agfa-Gevaert NV a Buy, Sell or Hold?
-
The current Agfa-Gevaert NV [AFGVY] share price is $1.33. The Score for AFGVY is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
-
AFGVY is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
69
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $43.42. The Score for ALGS is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
-
ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AFGVY Stock Price Chart
What is Agfa-Gevaert NV's stock price today?
-
The Agfa-Gevaert NV share price today is $1.33Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AFGVY is experiencing slight buying pressure.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $43.42Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
AFGVY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.12 | Sell |
Relative Strength Index (14 RSI): | 0 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.38 - 1.44) | Sell |
Bollinger Bands (100): | (1.69 - 2.75) | Sell |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.14 | Buy |
Relative Strength Index (14 RSI): | 74.33 | Buy |
Chaikin Money Flow: | 210748 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (27.82 - 40.1) | Buy |
Bollinger Bands (100): | (6.77 - 28.07) | Buy |
AFGVY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.39 | Sell |
20-day SMA: | 1.41 | Sell |
50-day SMA: | 1.84 | Sell |
200-day SMA: | 2.43 | Sell |
8-day EMA: | 1.37 | Sell |
20-day EMA: | 1.45 | Sell |
50-day EMA: | 1.74 | Sell |
200-day EMA: | 2.84 | Sell |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.78 | Buy |
20-day SMA: | 36.11 | Buy |
50-day SMA: | 23.97 | Buy |
200-day SMA: | 16.97 | Buy |
8-day EMA: | 40.32 | Buy |
20-day EMA: | 35.95 | Buy |
50-day EMA: | 27.43 | Buy |
200-day EMA: | 19.22 | Buy |
Agfa-Gevaert NV Earnings Growth & AFGVY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.65 per share, and a decrease next year of $0.14 per share.
Agfa-Gevaert NV Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |